Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04031404 · ClinicalTrials.gov registry record · NA
Glucose and Non-Invasive Brain Stimulation
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Terminated
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT04031404 is a NA study that was terminated before completion, run by University of North Carolina, Chapel Hill. The registered enrollment target is 23 participants.
The verdict
NCT04031404, a NA study, was terminated before completion, sponsored by University of North Carolina, Chapel Hill.
- TERMINATED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
Purpose: In this study, the investigators will delineate how brain network dynamics are modulated by experimentally induced elevated blood glucose levels and examine how glucose levels gate neuronal excitability measured by the response to TMS. Participants: Participants must be between the ages of 18 and 65 with no known diabetes, no known adverse reaction to finger prick blood draw, and no known neurological or psychiatric illness. Participants must have a body-mass index less than 30. Procedures: Participants will consume either a drink that contains 75 g of glucose or a placebo, and their response to TMS will be measured to examine the effect of glucose on motor cortex excitability.
Interventions
- DEVICE Single-pulse TMS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2019-09-11 |
| Est. Completion | 2020-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04031404
The ClinicalTrials.gov registry entry for NCT04031404 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Single-pulse TMS is the first listed.
NCT04031404 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04031404 about?
NCT04031404 is a clinical study titled "Glucose and Non-Invasive Brain Stimulation". Purpose: In this study, the investigators will delineate how brain network dynamics are modulated by experimentally induced elevated blood glucose levels and examine how glucose levels gate neuronal excitability measured by the response to TMS. Participants: Participants must be between the ages of...
What is the current status of trial NCT04031404?
This trial is currently terminated. It is a NA study. The enrollment target is 23 participants. The study started on 2019-09-11. Estimated completion is 2020-08-31.
What interventions are being tested in trial NCT04031404?
The interventions under investigation include: Single-pulse TMS (DEVICE).
Who is sponsoring clinical trial NCT04031404?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.